We assessed the therapy effects of a single injection of radiolabeled CD3xTRP1 and control bsAbs by measuring tumor sizes and evaluating the tumor microenvironment for CD3, CD8, Ly6G, F4/80, and PD-L1. The gene discussed is CD8A; the disease is neoplasm.